Ocean Park Asset Management LLC Takes $2.42 Million Position in SPDR S&P Biotech ETF $XBI

Ocean Park Asset Management LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 15,323 shares of the exchange traded fund’s stock, valued at approximately $2,425,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bank of America Corp DE grew its position in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after acquiring an additional 1,700,851 shares in the last quarter. Morgan Stanley boosted its stake in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the period. Wells Fargo & Company MN grew its holdings in shares of SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares in the last quarter. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $256,053,000. Finally, Bessemer Group Inc. increased its stake in SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after buying an additional 220,244 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.0%

SPDR S&P Biotech ETF stock opened at $158.07 on Wednesday. SPDR S&P Biotech ETF has a 52-week low of $85.37 and a 52-week high of $165.71. The firm has a market cap of $10.32 billion, a PE ratio of 11.47 and a beta of 0.83. The company’s 50 day moving average is $149.09 and its two-hundred day moving average is $135.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.